FDA Reclassifies Knee Joints

Article

WASHINGTON -- The Food and Drug Administration (FDA) has reclassified two fixed-bearing knee joint prostheses, the patellofemorotibial and the femorotibial (uni-compartmental) metal/polymer porous-coated uncemented prosthesis, from class III devices (i.e., premarket approval) to class II devices (i.e., special controls).

The special control that will apply to the patellofemorotibial prosthesis, used for whole knee joint replacement, and the femorotibial prosthesis, used for partial knee joint replacement, is titled "Class II Special Controls Guidance Document: Knee Joint Patellofemorotibial and Femorotibial Metal/Polymer Porous-coated Uncemented Prostheses; Guidance for Industry and FDA."

The FDA reasoned that special controls, in addition to general controls, will provide reasonable assurance of the safety and effectiveness of the devices. The rule was effective March 24, 2003. For more information, visit http://www.fda.gov/OHRMS/DOCKETS/98fr/ 03-6857.html.

Newsletter

Stay prepared and protected with Infection Control Today's newsletter, delivering essential updates, best practices, and expert insights for infection preventionists.

Recent Videos
David J. Weber, MD, MPH, president of the Society for Healthcare Epidemiology of America
Brenna Doran PhD, MA, hospital epidemiology and infection prevention for the University of California, San Francisco, and a coach and consultant of infection prevention; Jessica Swain, MBA, MLT, director of infection prevention and control for Dartmouth Health in Lebanon, New Hampshire; and Shanina Knighton, associate professor at Case Western Reserve University School of Nursing and senior nurse scientist at MetroHealth System in Cleveland, Ohio
Brenna Doran PhD, MA, hospital epidemiology and infection prevention for the University of California, San Francisco, and a coach and consultant of infection prevention; Jessica Swain, MBA, MLT, director of infection prevention and control for Dartmouth Health in Lebanon, New Hampshire; and Shanina Knighton, associate professor at Case Western Reserve University School of Nursing and senior nurse scientist at MetroHealth System in Cleveland, Ohio
© 2025 MJH Life Sciences

All rights reserved.